Chemoinformaics analysis of THIAZOLIDINE-4-CARBOXYLIC ACID
| Molecular Weight | 133.172 | nRot | 1 |
| Heavy Atom Molecular Weight | 126.116 | nRig | 6 |
| Exact Molecular Weight | 133.02 | nRing | 1 |
| Solubility: LogS | -1.758 | nHRing | 1 |
| Solubility: LogP | -1.974 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 15 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 7 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 4 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 16.9516 |
| nHD | 2 | BPOL | 10.9204 |
| QED | 0.517 |
| Synth | 3.533 |
| Natural Product Likeliness | 0.52 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.002 |
| HIA | 0.01 |
| CACO-2 | -5.893 |
| MDCK | 0.00000353 |
| BBB | 0.522 |
| PPB | 0.0786613 |
| VDSS | 0.592 |
| FU | 0.908594 |
| CYP1A2-inh | 0.013 |
| CYP1A2-sub | 0.089 |
| CYP2c19-inh | 0.034 |
| CYP2c19-sub | 0.061 |
| CYP2c9-inh | 0.035 |
| CYP2c9-sub | 0.74 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.352 |
| CYP3a4-inh | 0.011 |
| CYP3a4-sub | 0.027 |
| CL | 4.838 |
| T12 | 0.81 |
| hERG | 0.013 |
| Ames | 0.008 |
| ROA | 0.045 |
| SkinSen | 0.384 |
| Carcinogencity | 0.471 |
| EI | 0.718 |
| Respiratory | 0.387 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.946707 |